Data silos are undermining drug development and failing rare disease patients

Data silos are proliferating while research and development activity explode following genetic and immunological advances for many clinically described disorders with previously unknown etiologies. The latter event has inspired optimism in the patient, clinical, and research communities that disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Denton, Nathan, Molloy, Monique, Charleston, Samantha, Lipset, Craig, Hirsch, Jonathan, Mulberg, Andrew E., Howard, Paul, Marsh, Eric D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Position Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025897/
https://www.ncbi.nlm.nih.gov/pubmed/33827602
http://dx.doi.org/10.1186/s13023-021-01806-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025897/
https://www.ncbi.nlm.nih.gov/pubmed/33827602
http://dx.doi.org/10.1186/s13023-021-01806-4

Ejemplares similares